fda glp-1 warning news november 2025 Drug Recalls and Warnings: Illegal Sales and Misleading Marketing by Novo Nordisk and Eli Lilly FDA Sends Warning Letters to

A novel glucagon-like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice

Avoid lying down immediately after eating , as this can worsen symptoms

SELECT, Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) trial

The new programs starting dose is 25% of the lowest starting dose in Nooms other GLP-1 offerings

Here are some medical journals and scholarly articles discussing the correlation of GLP-1, PCOS and Weight Loss: Do GLP-1 Analogs Have a Place in the Treatment of PCOS

If the FDA verifies that a corrective action has been taken, it may issue a close-out letter